News

Our news coverage is separated into two main sections — Industry News and Scientific News.

Industry News includes updates on company news, corporate changes and product developments, while we cover clinical trials and regulatory matters under Scientific News.

Industry News

      

Scientific News

newsimg-ind

newsimg-sci

04.05.18 | NUVO PHARMACEUTICALS ORDINARY SHARES (NRIFF) SI Increased By 1540%

A report by Jan Rainey published on April 29th 2018, suggests that NUVO PHARMACEUTICALS INC ORDINARY SHARES (OTCMKTS: NRIFF) had an increase of 1540% in short interest.

11.01.18 | Nuvo Pharmaceuticals acquires global rights for Head Lice Treatment

Nuvo Pharmaceuticals announced that it had acquired the global rights for Resultz, a head lice treatment from Piedmont Pharmaceuticals.

15.12.17 | Alliance Pharma buys the head lice treatment Vamousse from Tyra Tech for $13m.

The speciality pharmaceutical company, Alliance Pharma has added Vamousee to its portfolio after agreeing to buy the pesticide-free head lice treatment from Tyra Tech for $13m (£9.6m).

15.12.17 | Safety, Efficacy, and Physicochemical Characterization of T. crispa Ointment

A new study investigating a community-based pediculicidal ointment, Tinospora crispa, has revealed that T. crispa pediculicidal ointment is safe, effective and has acceptable physicochemical characteristics.

22.02.17 | Assessment of oral ivermectin versus shampoo in the treatment of pediculosis

A study conducted in two neighbouring villages of Sine-Saloum, Senagal, analysed the effect of using oral Ivermectin and shampoo in the treatment of pediculosis and revealed that whilst oral ivermectin is more highly effective in treating pediculosis compared with shampoo, ivermectin resitance may emerge during treatment.

04.05.18 | Molecular Survey of Head and Body Lice, Pediculus humanus, in France

A new study has examined the genetic diversity of head and body lice collected from Bobigny, which is located near Paris (France), and confirmed for the first time the presence of clade E head lice in France. Clade E has upto this point been found mainly in lice from West Africa.

27.02.18 | Response of Pediculus humanus capitis to Volatiles of Whole and Individual Components of the Human Scalp

A new study has evaluated the response of head lice to volatiles that emanate from the human scalp, identifying the volatile components of the odor and the attractive or repellent activity of their pure main components.

11.01.18 | In vitro efficacy of five essential oils against Pediculus humanus capitis

A new study has assessed the in vitro efficacy of five essential oils against adults of Pediculus humanus capitis using a contact filter paper toxicity bioassay and revealed that Clove oil diluted either in coco oil or sunflower oil demonstrated the best adulticidal activity reaching over 90% within 2 hours in lice submitted to a 30 minute contact.

11.01.18 | The unusual reproductive system of head and body lice (Pediculus humanus)

A new study has conclusively established for the first time that both head and body lice reproduce through paternal genome elimination (PGE), an unusual genetic system in which males transmit only their maternally derived chromosomes.

11.01.18 | In vitro Investigation of the Pediculicidal Activities of the Volatile Oil Components of Some Medical Plants Raised in Turkey

A new study aimed at assessing the in vitro pediculicidal activities of volatile oils extracted from 10 medical plants raised in Turkey has revealed that the volatile oil extract (Rosmarinus officinalis) from the rosemary medical plant was more effective than the other oils.

Join us on Twitter

Site Map   |    Privacy Policy   |   Terms & Conditions

© 2012-2013 pediculosis.com — all rights reserved